USER TESTED
“Involving the operational end user is a key piece of medical product development that
was previously under-represented.”
which can help illuminate both the bene- fits and the limitations of each.
THE NECESSITY OF FEEDBACK “User feedback was very important, because we received some very interest- ing responses from medics that differed from providers, who have more training and experience, and may be much more critical of these devices,” said Sanjakdar. “Te providers can compare their own abilities to what each device offers, and it will be a more stringent comparison than that from the medic, who may not have the same medical background to assess TBI as thoroughly as a trained neurosur- geon or neurologist.”
During her assignment, Sanjakdar met with nearly 160 medical personnel, which
included nurses, physician assistants and medics. She explained that her team specifically reached out to the entire spec- trum of medical care as, inherently, there will be different perspectives at the differ- ent roles of care, and from the different types of caregivers as well.
In her role as a product manager at USAMMDA, under the umbrella of the USAMRDC and its higher headquarters, the U.S. Army Futures Command, Sanjak- dar clearly understands the importance of being both “effective” and “innovative” in her team’s approach to product develop- ment. However, she also realizes the value of “agility” in this process, and recognizes the significance of failing early and respon- sibly, in order to learn from an unfavorable situation and parlay this knowledge into future success.
“From this single mission, our users have communicated to us what they would like to see, and it has helped to better define the requirements and path forward in the Warfighter Brain Health PMO,” she said.
Sanjakdar explained that the respec-
tive programs for both devices are now backtracking a bit, because the detailed feedback helped to identify previously unrealized user requirements. Te infor- mation collected from the users in theater indicated a lack of operational effectiveness and suitability for both devices, although one of the devices may be accepted if it is improved based upon the findings.
“Te WBH PMO has considered all of these key recommendations to help refine requirements for products to best meet user needs,” said Sanjakdar. “Our group is now conducting a more thorough market analysis to see what other products may be available to better meet the needs of the end users. Also, from the feedback we received, we are currently developing electronic tablet apps that could aid in the
DEPLOYED EXPERTISE
Sanjakdar, right, conducts training and assessment of FDA-approved TBI screening devices with the medics, physician assistants and providers at the Shorab Role 2 medical facility in Helmand Province, Afghanistan. She solicited input from 158 medical personnel during her four-week trip.
130
Army AL&T Magazine
Fall 2020
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196
